Cholestasis: Clinical Trials

5 trials for Cholestasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 recruiting, 1 unknown. 5 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 15Completed 2, Active not recruiting 1, Recruiting 1, Unknown 1

Follow Cholestasis: new trials by email Literature Review of Cholestasis trials Research Report on Cholestasis

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis
Indocyanine Green - Biliary Atresia, Kasai
Early Phase 1RecruitingUniversity of Alabama at Birmingham152026-01-232026-02-18
Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)
Fenofibrate - Primary Biliary Cholangitis (PBC)
Early Phase 1Active not recruitingXijing Hospital of Digestive Diseases152025-03-132026-07-29
A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis
Fenofibrate, UDCA (Ursodeoxycholic acid) - Primary Biliary Cholangitis (PBC)
Early Phase 1CompletedHan Ying302024-09-142026-08-05
Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases
T cell injection targeting CD19 chimeric antigen receptor - Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies
Early Phase 1UnknownPersonGen BioTherapeutics (Suzhou) Co., Ltd.102024-05-142024-05-16
Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CT
Obeticholic acid, Placebos - Primary Biliary Cirrhosis
Early Phase 1CompletedUniversity of Aarhus82016-05-192019-11-01

Narrower conditions

Liver Cirrhosis, Biliary (4)  ·  Arthritis, Rheumatoid (1)  ·  Biliary Atresia (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Myositis (1)  ·  Purpura, Thrombocytopenic, Idiopathic (1)  ·  Scleroderma, Systemic (1)  ·  Sjogren's Syndrome (1)

Broader conditions

Bile Duct Diseases (5)  ·  Biliary Tract Diseases (5)  ·  Digestive System Diseases (5)  ·  Cholestasis, Intrahepatic (4)  ·  Fibrosis (4)  ·  Liver Cirrhosis (4)  ·  Liver Diseases (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Arthritis (1)  ·  Autoimmune Diseases (1)  ·  Blood Coagulation Disorders (1)  ·  Blood Platelet Disorders (1)  ·  Congenital Abnormalities (1)

Interventions

Fenofibrate (2)  ·  Indocyanine Green (1)  ·  Ursodeoxycholic Acid (1)  ·  obeticholic acid (1)

Sponsors

Han Ying (1)  ·  PersonGen BioTherapeutics (Suzhou) Co., Ltd. (1)  ·  University of Aarhus (1)  ·  University of Alabama at Birmingham (1)  ·  Xijing Hospital of Digestive Diseases (1)

Countries

China (2)  ·  Denmark (1)  ·  United States (1)

Top investigators

Laura Stafman, MD (1)  ·  Susanne Keiding, prof (1)

Results publications

PMID 22454486, PMID 26966160, PMID 28249726, PMID 32717289